Edward M. Kaye M.D., Director at CYTOKINETICS INC (CYTK), sold 56,128 shares at $66.72 ($3.7M) on 2025-12-01, disclosed to the SEC on 2025-12-02.
Scheduled sale ($3.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.72 | 28,064 | $1.9M | 50.0% |
| 2 | $66.72 | 28,064 | $1.9M | 50.0% |
| Total | $66.72 avg | 56,128 | $3.7M | 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |